United States Flu Vaccine Market Outlook and forecast to 2024
United States flu vaccine market is expected to reach nearly US$ 3 Billion by 2024. Growth in US flu vaccine market can be attributed to factors such as increased disease awareness, expanded recommendations by governmental and advisory bodies to be vaccinated against flu vaccine and introduction of quadrivalent flu vaccine. Long–term Growth Projection and Development: • Sanofi to Acquire Protein Sciences Corporation • It is likely that more than 185 Million persons being vaccinated with flu vaccines in 2024.
Big Data in Tourism – Market Research Reports 2018